These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

620 related items for PubMed ID: 12414853

  • 21. Evaluation of bone loss and its mechanisms in anorexia nervosa.
    Legroux-Gérot I, Vignau J, D'Herbomez M, Collier F, Marchandise X, Duquesnoy B, Cortet B.
    Calcif Tissue Int; 2007 Sep; 81(3):174-82. PubMed ID: 17668143
    [Abstract] [Full Text] [Related]

  • 22. The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement or calcium supplementation.
    Rosen CJ, Chesnut CH, Mallinak NJ.
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1904-10. PubMed ID: 9177404
    [Abstract] [Full Text] [Related]

  • 23. Effect of dehydroepiandrosterone on bone mass, serum lipids, and dimethylbenz(a)anthracene-induced mammary carcinoma in the rat.
    Luo S, Labrie C, Bélanger A, Labrie F.
    Endocrinology; 1997 Aug; 138(8):3387-94. PubMed ID: 9231792
    [Abstract] [Full Text] [Related]

  • 24. The relationship of biochemical markers of bone turnover to bone density changes in postmenopausal women: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial.
    Marcus R, Holloway L, Wells B, Greendale G, James MK, Wasilauskas C, Kelaghan J.
    J Bone Miner Res; 1999 Sep; 14(9):1583-95. PubMed ID: 10469288
    [Abstract] [Full Text] [Related]

  • 25. Bone mineral density response to estrogen replacement in frail elderly women: a randomized controlled trial.
    Villareal DT, Binder EF, Williams DB, Schechtman KB, Yarasheski KE, Kohrt WM.
    JAMA; 2001 Aug 15; 286(7):815-20. PubMed ID: 11497535
    [Abstract] [Full Text] [Related]

  • 26. Effect of DHEA supplementation on serum IGF-1, osteocalcin, and bone mineral density in postmenopausal, glucocorticoid-treated women.
    Papierska L, Rabijewski M, Kasperlik-Załuska A, Zgliczyński W.
    Adv Med Sci; 2012 Jun 01; 57(1):51-7. PubMed ID: 22430044
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Comparison of the effects of raloxifene and low-dose hormone replacement therapy on bone mineral density and bone turnover in the treatment of postmenopausal osteoporosis.
    Dane C, Dane B, Cetin A, Erginbas M.
    Gynecol Endocrinol; 2007 Jul 01; 23(7):398-403. PubMed ID: 17701771
    [Abstract] [Full Text] [Related]

  • 29. Levonorgestrel and 17beta-estradiol given transdermally for the prevention of postmenopausal osteoporosis.
    Warming L, Ravn P, Christiansen C.
    Maturitas; 2005 Feb 14; 50(2):78-85. PubMed ID: 15653003
    [Abstract] [Full Text] [Related]

  • 30. Clinical and biochemical determinants of bone metabolism and bone mass in adolescent female patients with anorexia nervosa.
    Audí L, Vargas DM, Gussinyé M, Yeste D, Martí G, Carrascosa A.
    Pediatr Res; 2002 Apr 14; 51(4):497-504. PubMed ID: 11919336
    [Abstract] [Full Text] [Related]

  • 31. Preservation of neuroendocrine control of reproductive function despite severe undernutrition.
    Miller KK, Grinspoon S, Gleysteen S, Grieco KA, Ciampa J, Breu J, Herzog DB, Klibanski A.
    J Clin Endocrinol Metab; 2004 Sep 14; 89(9):4434-8. PubMed ID: 15356043
    [Abstract] [Full Text] [Related]

  • 32. Effect of dehydroepiandrosterone supplementation on bone mineral density, bone markers, and body composition in older adults: the DAWN trial.
    von Mühlen D, Laughlin GA, Kritz-Silverstein D, Bergstrom J, Bettencourt R.
    Osteoporos Int; 2008 May 14; 19(5):699-707. PubMed ID: 18084691
    [Abstract] [Full Text] [Related]

  • 33. Long-term metreleptin treatment increases bone mineral density and content at the lumbar spine of lean hypoleptinemic women.
    Sienkiewicz E, Magkos F, Aronis KN, Brinkoetter M, Chamberland JP, Chou S, Arampatzi KM, Gao C, Koniaris A, Mantzoros CS.
    Metabolism; 2011 Sep 14; 60(9):1211-21. PubMed ID: 21741057
    [Abstract] [Full Text] [Related]

  • 34. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study.
    Morabito N, Crisafulli A, Vergara C, Gaudio A, Lasco A, Frisina N, D'Anna R, Corrado F, Pizzoleo MA, Cincotta M, Altavilla D, Ientile R, Squadrito F.
    J Bone Miner Res; 2002 Oct 14; 17(10):1904-12. PubMed ID: 12369794
    [Abstract] [Full Text] [Related]

  • 35. Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism.
    Guo CY, Thomas WE, al-Dehaimi AW, Assiri AM, Eastell R.
    J Clin Endocrinol Metab; 1996 Oct 14; 81(10):3487-91. PubMed ID: 8855790
    [Abstract] [Full Text] [Related]

  • 36. Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study.
    Garnero P, Sornay-Rendu E, Claustrat B, Delmas PD.
    J Bone Miner Res; 2000 Aug 14; 15(8):1526-36. PubMed ID: 10934651
    [Abstract] [Full Text] [Related]

  • 37. Effects of intranasal 17beta-estradiol on bone turnover and serum insulin-like growth factor I in postmenopausal women.
    Garnero P, Tsouderos Y, Marton I, Pelissier C, Varin C, Delmas PD.
    J Clin Endocrinol Metab; 1999 Jul 14; 84(7):2390-7. PubMed ID: 10404809
    [Abstract] [Full Text] [Related]

  • 38. Bone remodeling and bone mineral density during pregnancy.
    Ulrich U, Miller PB, Eyre DR, Chesnut CH, Schlebusch H, Soules MR.
    Arch Gynecol Obstet; 2003 Oct 14; 268(4):309-16. PubMed ID: 14504876
    [Abstract] [Full Text] [Related]

  • 39. A prospective study of changes in bone turnover and bone density associated with regaining weight in women with anorexia nervosa.
    Bolton JG, Patel S, Lacey JH, White S.
    Osteoporos Int; 2005 Dec 14; 16(12):1955-62. PubMed ID: 16027954
    [Abstract] [Full Text] [Related]

  • 40. High bone density in hyperandrogenic women: effect of gonadotropin-releasing hormone agonist alone or in conjunction with estrogen-progestin replacement.
    Simberg N, Tiitinen A, Silfvast A, Viinikka L, Ylikorkala O.
    J Clin Endocrinol Metab; 1996 Feb 14; 81(2):646-51. PubMed ID: 8636283
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.